Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)

Alterity Therapeutics (ATHE) posted quarterly Change in Account Payables of -$458036.1 for Q2 2020, down 197.83% year-on-year from $468174.7 in Q3 2019, and down 791.62% on a QoQ basis from $66226.9 in Q4 2019.

Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020) Analysis & Trends

Alterity Therapeutics (ATHE) has reported Change in Account Payables for 11 consecutive years, with -$458036.1 the latest figure, recorded in Q2 2020.

  • Quarterly Change in Account Payables fell 197.83% year-over-year to -$458036.1 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was -$330323.2 (down 95.97% YoY) and the FY2025 annual result came in at -$1.4 million, down 285.48% from the prior year.
  • Change in Account Payables fell to -$458036.1 in Q2 2020 per ATHE's latest filing, from $66226.9 in the prior quarter.
  • Over the last five years, Change in Account Payables for ATHE reached as high as $468174.7 in Q2 2019 and fell as low as -$604620.8 in Q2 2017.
  • A 5-year average of -$190231.9 and a median of -$262171.1 in 2016 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2019 — Change in Account Payables surged 5601.06% — and 2020, when it sank 197.83%.
  • Year by year, Change in Account Payables stood at -$262171.1 in 2016, then increased by 9.12% to -$238258.3 in 2017, then tumbled by 70.69% to -$406688.7 in 2018, then jumped by 116.28% to $66226.9 in 2019, then sank by 791.62% to -$458036.1 in 2020.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$458036.1, $66226.9, and $468174.7 for Q2 2020, Q4 2019, and Q2 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Alterity Therapeutics 30.00 Bn 30.00 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 -458,036.14
Jun 30, 2020 -458,036.14
Dec 31, 2019 66,226.92
Dec 31, 2019 66,226.92
Jun 30, 2019 468,174.70
Jun 30, 2019 468,174.70
Dec 31, 2018 -406,688.66
Dec 31, 2018 -406,688.66
Jun 30, 2018 8,212.07
Jun 30, 2018 8,212.07
Dec 31, 2017 -238,258.31
Dec 31, 2017 -238,258.31
Jun 30, 2017 -604,620.84
Jun 30, 2017 -604,620.84
Dec 31, 2016 -262,171.08
Dec 31, 2016 -262,171.08
Jun 30, 2016 -284,925.64
Jun 30, 2016 -284,925.64
Dec 31, 2015 -268,936.71
Dec 31, 2015 -268,936.71